309 related articles for article (PubMed ID: 27584023)
1. Cancer immunotherapy: new applications in urologic oncology.
Mullane SA; Bellmunt J
Curr Opin Urol; 2016 Nov; 26(6):556-63. PubMed ID: 27584023
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in immunotherapy for urological cancer.
Obara W; Kato R; Kato Y; Kanehira M; Takata R
Int J Urol; 2017 Oct; 24(10):735-742. PubMed ID: 28636222
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunotherapy: new applications in urologic oncology.
Hurwitz ME; Sokhn J; Petrylak DP
Curr Opin Urol; 2016 Nov; 26(6):535-42. PubMed ID: 27584025
[TBL] [Abstract][Full Text] [Related]
4. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
5. The Role of Immunotherapy in Urologic Cancers.
May A; Roustio L; Hamilton ZA
Mo Med; 2020; 117(2):127-132. PubMed ID: 32308237
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in immuno-oncology and its application to urological cancers.
Mataraza JM; Gotwals P
BJU Int; 2016 Oct; 118(4):506-14. PubMed ID: 27123757
[TBL] [Abstract][Full Text] [Related]
7. [Urothelial tumors in 2016: Are we at the dawn of a new diagnostic and therapeutic era?].
Pfister C
Ann Pathol; 2016 Dec; 36(6):369-370. PubMed ID: 27912839
[No Abstract] [Full Text] [Related]
8. Biomarkers for immunotherapy in urological cancers.
Gust KM; Resch I; D'Andrea D
Curr Opin Urol; 2018 Jan; 28(1):25-28. PubMed ID: 29120910
[TBL] [Abstract][Full Text] [Related]
9. Personalized peptide vaccines and their relation to other therapies in urological cancer.
Kimura T; Egawa S; Uemura H
Nat Rev Urol; 2017 Aug; 14(8):501-510. PubMed ID: 28561807
[TBL] [Abstract][Full Text] [Related]
10. Cancer immunotherapy: A paradigm shift in the treatment of advanced urologic cancers.
Gill DM; Agarwal N
Urol Oncol; 2017 Dec; 35(12):676-677. PubMed ID: 29054496
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy and Checkpoint Inhibitors in Urologic Cancer.
Walasek A; Zlatev DV
Urol Clin North Am; 2022 May; 49(2):323-334. PubMed ID: 35428437
[TBL] [Abstract][Full Text] [Related]
12. Novel therapies for advanced urologic cancers.
Heidenreich A
Curr Opin Urol; 2020 Jul; 30(4):594-601. PubMed ID: 32453002
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy with radiotherapy in urological malignancies.
Mehta S; Illidge T; Choudhury A
Curr Opin Urol; 2016 Nov; 26(6):514-22. PubMed ID: 27552139
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in kidney cancer: the past, present, and future.
Hammers H
Curr Opin Urol; 2016 Nov; 26(6):543-7. PubMed ID: 27533501
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy in urology: Concept and results].
Pignot G; Houede N
Prog Urol; 2019 Nov; 29(15):922-928. PubMed ID: 31477432
[TBL] [Abstract][Full Text] [Related]
16. Future directions in urological oncology.
Thompson RH
BJU Int; 2015 Apr; 115(4):499. PubMed ID: 25808707
[No Abstract] [Full Text] [Related]
17. [Renaissance of immuno-oncology for urological tumors : Current status].
Grimm MO; Winkler Y; Fetter I; Oppel-Heuchel H
Urologe A; 2016 May; 55(5):621-6. PubMed ID: 27119960
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy advances in uro-genital malignancies.
Ratta R; Zappasodi R; Raggi D; Grassi P; Verzoni E; Necchi A; Di Nicola M; Salvioni R; de Braud F; Procopio G
Crit Rev Oncol Hematol; 2016 Sep; 105():52-64. PubMed ID: 27372200
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of urologic tumors: principles and progress.
Broghammer EL; Ratliff TL
Urol Oncol; 2002; 7(2):45-56. PubMed ID: 12474522
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for genitourinary cancer: state of the art and new perspectives.
Cattrini C; Dellepiane C; Cavo A; Buzzatti G; Tolomeo F; Messina C; Boccardo F
Anticancer Drugs; 2016 Aug; 27(7):585-99. PubMed ID: 27183027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
